Home / Companies / News / US charges generic drug firm Glenmark with conspiracy in price-fixing

US charges generic drug firm Glenmark with conspiracy in price-fixing

Company says it strongly disagreed with the charge, has 'overwhelming evidence' to support its innocence.

MNCs raise concerns around the definition of inventions, provisions for compulsory licensing

premium

Some major Western concerns about India's patent framework are the definitions of inventions and provisions for compulsory licensing

Reuters Washington

1 min read Last Updated : Jul 01 2020 | 9:29 PM IST

Glenmark Pharmaceuticals USA was charged on Tuesday with conspiring to fix prices for generic drugs, the U.S. Justice Department said in a statement.

Glenmark allegedly conspired with pharmaceutical maker Apotex Corp and other generic drug companies to increase the prices of cholesterol medication pravastatin and other generic drugs, the department said.

Glenmark said it strongly disagreed with the charge. “We will continue to vigorously defend against these allegations that we know to be false, and we are confident the overwhelming evidence will make that clear,” the company said in a statement.

The charge was filed in U.S. District Court in Philadelphia.

The price-fixing conspiracy allegedly took place from 2013 to 2015 and caused a loss to victims of at least $200 million, according to the department.

The charge against Apotex was resolved in May by a deferred prosecution agreement in which the company agreed to pay $24 million.

Topics : Glenmark generic drugs Pharma industry